Slow-channel transgenic mice: A model of postsynaptic organellar degeneration at the neuromuscular junction

Christopher M. Gomez, Ricardo A Maselli, Jo Ellen Gundeck, Mary Chao, John W. Day, Shiori Tamamizu, Jose A. Lasalde, Mark McNamee, Robert L. Wollmann

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The slow-channel congenital myasthenic syndrome (SCCMS) is a dominantly inherited disorder of neuromuscular transmission characterized by delayed closure of the skeletal muscle acetylcholine receptor (AChR) ion channel and degeneration of the neuromuscular junction. The identification of a series of AChR subunit mutations in the SCCMS supports the hypothesis that the altered kinetics of the endplate currents in this disease are attributable to inherited abnormalities of the AChR. To investigate the role of these mutant AChR subunits in the development of the synaptic degeneration seen in the SCCMS, we have studied the properties of the AChR mutation, εL269F, found in a family with SCCMS, using both in vitro and in vivo expression systems. The mutation causes a sixfold increase in the open time of AChRs expressed in vitro, similar to the phenotype of other reported mutants. Transgenic mice expressing this mutant develop a syndrome that is highly reminiscent of the SCCMS. Mice have fatigability of limb muscles, electrophysiological evidence of slow AChR ion channels, and defective neuromuscular transmission. Pathologically, the motor endplates show focal accumulation of calcium and striking ultrastructural changes, including enlargement and degeneration of the subsynaptic mitochondria and nuclei. These findings clearly demonstrate the role of this mutation in the spectrum of abnormalities associated with the SCCMS and point to the subsynaptic organelles as principal targets in this disease. These transgenic mice provide a useful model for the study of excitotoxic synaptic degeneration.

Original languageEnglish (US)
Pages (from-to)4170-4179
Number of pages10
JournalJournal of Neuroscience
Volume17
Issue number11
StatePublished - 1997

Fingerprint

Congenital Myasthenic Syndromes
Neuromuscular Junction
Cholinergic Receptors
Transgenic Mice
Mutation
Ion Channels
Neuromuscular Junction Diseases
Motor Endplate
Organelles
Mitochondria
Skeletal Muscle
Extremities
Calcium
Phenotype
Muscles

Keywords

  • acetylcholine receptor
  • calcium overload
  • excitotoxicity
  • neuromuscular junction
  • point mutation
  • slow-channel congenital myasthenic syndrome
  • synaptic degeneration
  • transgenic mice

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Gomez, C. M., Maselli, R. A., Gundeck, J. E., Chao, M., Day, J. W., Tamamizu, S., ... Wollmann, R. L. (1997). Slow-channel transgenic mice: A model of postsynaptic organellar degeneration at the neuromuscular junction. Journal of Neuroscience, 17(11), 4170-4179.

Slow-channel transgenic mice : A model of postsynaptic organellar degeneration at the neuromuscular junction. / Gomez, Christopher M.; Maselli, Ricardo A; Gundeck, Jo Ellen; Chao, Mary; Day, John W.; Tamamizu, Shiori; Lasalde, Jose A.; McNamee, Mark; Wollmann, Robert L.

In: Journal of Neuroscience, Vol. 17, No. 11, 1997, p. 4170-4179.

Research output: Contribution to journalArticle

Gomez, CM, Maselli, RA, Gundeck, JE, Chao, M, Day, JW, Tamamizu, S, Lasalde, JA, McNamee, M & Wollmann, RL 1997, 'Slow-channel transgenic mice: A model of postsynaptic organellar degeneration at the neuromuscular junction', Journal of Neuroscience, vol. 17, no. 11, pp. 4170-4179.
Gomez, Christopher M. ; Maselli, Ricardo A ; Gundeck, Jo Ellen ; Chao, Mary ; Day, John W. ; Tamamizu, Shiori ; Lasalde, Jose A. ; McNamee, Mark ; Wollmann, Robert L. / Slow-channel transgenic mice : A model of postsynaptic organellar degeneration at the neuromuscular junction. In: Journal of Neuroscience. 1997 ; Vol. 17, No. 11. pp. 4170-4179.
@article{be0df89c5b8745e1b80abba2faa65bf2,
title = "Slow-channel transgenic mice: A model of postsynaptic organellar degeneration at the neuromuscular junction",
abstract = "The slow-channel congenital myasthenic syndrome (SCCMS) is a dominantly inherited disorder of neuromuscular transmission characterized by delayed closure of the skeletal muscle acetylcholine receptor (AChR) ion channel and degeneration of the neuromuscular junction. The identification of a series of AChR subunit mutations in the SCCMS supports the hypothesis that the altered kinetics of the endplate currents in this disease are attributable to inherited abnormalities of the AChR. To investigate the role of these mutant AChR subunits in the development of the synaptic degeneration seen in the SCCMS, we have studied the properties of the AChR mutation, εL269F, found in a family with SCCMS, using both in vitro and in vivo expression systems. The mutation causes a sixfold increase in the open time of AChRs expressed in vitro, similar to the phenotype of other reported mutants. Transgenic mice expressing this mutant develop a syndrome that is highly reminiscent of the SCCMS. Mice have fatigability of limb muscles, electrophysiological evidence of slow AChR ion channels, and defective neuromuscular transmission. Pathologically, the motor endplates show focal accumulation of calcium and striking ultrastructural changes, including enlargement and degeneration of the subsynaptic mitochondria and nuclei. These findings clearly demonstrate the role of this mutation in the spectrum of abnormalities associated with the SCCMS and point to the subsynaptic organelles as principal targets in this disease. These transgenic mice provide a useful model for the study of excitotoxic synaptic degeneration.",
keywords = "acetylcholine receptor, calcium overload, excitotoxicity, neuromuscular junction, point mutation, slow-channel congenital myasthenic syndrome, synaptic degeneration, transgenic mice",
author = "Gomez, {Christopher M.} and Maselli, {Ricardo A} and Gundeck, {Jo Ellen} and Mary Chao and Day, {John W.} and Shiori Tamamizu and Lasalde, {Jose A.} and Mark McNamee and Wollmann, {Robert L.}",
year = "1997",
language = "English (US)",
volume = "17",
pages = "4170--4179",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "11",

}

TY - JOUR

T1 - Slow-channel transgenic mice

T2 - A model of postsynaptic organellar degeneration at the neuromuscular junction

AU - Gomez, Christopher M.

AU - Maselli, Ricardo A

AU - Gundeck, Jo Ellen

AU - Chao, Mary

AU - Day, John W.

AU - Tamamizu, Shiori

AU - Lasalde, Jose A.

AU - McNamee, Mark

AU - Wollmann, Robert L.

PY - 1997

Y1 - 1997

N2 - The slow-channel congenital myasthenic syndrome (SCCMS) is a dominantly inherited disorder of neuromuscular transmission characterized by delayed closure of the skeletal muscle acetylcholine receptor (AChR) ion channel and degeneration of the neuromuscular junction. The identification of a series of AChR subunit mutations in the SCCMS supports the hypothesis that the altered kinetics of the endplate currents in this disease are attributable to inherited abnormalities of the AChR. To investigate the role of these mutant AChR subunits in the development of the synaptic degeneration seen in the SCCMS, we have studied the properties of the AChR mutation, εL269F, found in a family with SCCMS, using both in vitro and in vivo expression systems. The mutation causes a sixfold increase in the open time of AChRs expressed in vitro, similar to the phenotype of other reported mutants. Transgenic mice expressing this mutant develop a syndrome that is highly reminiscent of the SCCMS. Mice have fatigability of limb muscles, electrophysiological evidence of slow AChR ion channels, and defective neuromuscular transmission. Pathologically, the motor endplates show focal accumulation of calcium and striking ultrastructural changes, including enlargement and degeneration of the subsynaptic mitochondria and nuclei. These findings clearly demonstrate the role of this mutation in the spectrum of abnormalities associated with the SCCMS and point to the subsynaptic organelles as principal targets in this disease. These transgenic mice provide a useful model for the study of excitotoxic synaptic degeneration.

AB - The slow-channel congenital myasthenic syndrome (SCCMS) is a dominantly inherited disorder of neuromuscular transmission characterized by delayed closure of the skeletal muscle acetylcholine receptor (AChR) ion channel and degeneration of the neuromuscular junction. The identification of a series of AChR subunit mutations in the SCCMS supports the hypothesis that the altered kinetics of the endplate currents in this disease are attributable to inherited abnormalities of the AChR. To investigate the role of these mutant AChR subunits in the development of the synaptic degeneration seen in the SCCMS, we have studied the properties of the AChR mutation, εL269F, found in a family with SCCMS, using both in vitro and in vivo expression systems. The mutation causes a sixfold increase in the open time of AChRs expressed in vitro, similar to the phenotype of other reported mutants. Transgenic mice expressing this mutant develop a syndrome that is highly reminiscent of the SCCMS. Mice have fatigability of limb muscles, electrophysiological evidence of slow AChR ion channels, and defective neuromuscular transmission. Pathologically, the motor endplates show focal accumulation of calcium and striking ultrastructural changes, including enlargement and degeneration of the subsynaptic mitochondria and nuclei. These findings clearly demonstrate the role of this mutation in the spectrum of abnormalities associated with the SCCMS and point to the subsynaptic organelles as principal targets in this disease. These transgenic mice provide a useful model for the study of excitotoxic synaptic degeneration.

KW - acetylcholine receptor

KW - calcium overload

KW - excitotoxicity

KW - neuromuscular junction

KW - point mutation

KW - slow-channel congenital myasthenic syndrome

KW - synaptic degeneration

KW - transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=0030905263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030905263&partnerID=8YFLogxK

M3 - Article

C2 - 9151734

AN - SCOPUS:0030905263

VL - 17

SP - 4170

EP - 4179

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 11

ER -